Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

FucT-III rabbit pAb

The Lewis histo-blood group system comprises a set of fucosylated glycosphingolipids that are synthesized by exocrine epithelial cells and circulate in body fluids. The glycosphingolipids function in embryogenesis, tissue differentiation, tumor metastasis, inflammation, and bacterial adhesion. They are secondarily absorbed to red blood cells giving rise to their Lewis phenotype. This gene is a member of the fucosyltransferase family, which catalyzes the addition of fucose to precursor polysaccharides in the last step of Lewis antigen biosynthesis. It encodes an enzyme with alpha (1, 3)-fucosyltransferase and alpha (1, 4)-fucosyltransferase activities. Mutations in this gene are responsible for the majority of Lewis antigen-negative phenotypes. Multiple alternatively spliced variants, encoding the same protein, have been found for this gene. [provided by RefSeq, Jul 2008],

Product Specifications

Background

The Lewis histo-blood group system comprises a set of fucosylated glycosphingolipids that are synthesized by exocrine epithelial cells and circulate in body fluids. The glycosphingolipids function in embryogenesis, tissue differentiation, tumor metastasis, inflammation, and bacterial adhesion. They are secondarily absorbed to red blood cells giving rise to their Lewis phenotype. This gene is a member of the fucosyltransferase family, which catalyzes the addition of fucose to precursor polysaccharides in the last step of Lewis antigen biosynthesis. It encodes an enzyme with alpha (1,3) -fucosyltransferase and alpha (1,4) -fucosyltransferase activities. Mutations in this gene are responsible for the majority of Lewis antigen-negative phenotypes. Multiple alternatively spliced variants, encoding the same protein, have been found for this gene. [provided by RefSeq, Jul 2008]

UniProt

P21217

Swiss Prot

P21217

Reactivity

Human; Rat; Mouse

Immunogen

The antiserum was produced against synthesized peptide derived from human FUT3. AA range:91-140

Clonality

Polyclonal

Source

Rabbit

Applications

WB; IHC; IF; ELISA

Concentration

1 mg/ml

Dilution

Western Blot: 1/500 - 1/2000. Immunohistochemistry: 1/100 - 1/300. ELISA: 1/10000. Not yet tested in other applications.

Molecular Weight

42kD

Storage Conditions

-20°C/1 year

Observed Molecular Weight

42kD

Fragment

IgG

Subcellular Location

Golgi apparatus, Golgi stack membrane; Single-pass type II membrane protein . Membrane-bound form in trans cisternae of Golgi.

Other Product Names

FUT3; FT3B; LE; Galactoside 3 (4) -L-fucosyltransferase; Blood group Lewis alpha-4-fucosyltransferase; Lewis FT; Fucosyltransferase 3; Fucosyltransferase III; FucT-III

Gene ID (Human)

2525

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Cellulose, microcrystalline powder, 50 micron
GV0115-100g 100 g

Cellulose, microcrystalline powder, 50 micron

Ask
View Details
Vmn1r101 CRISPR All-in-one AAV vector set (with saCas9)(Mouse)
49523154 3x 1.0 µg DNA

Vmn1r101 CRISPR All-in-one AAV vector set (with saCas9)(Mouse)

Ask
View Details
Lentiviral mouse Mus81 shRNA (UAS) - Lentiviral mouse Mus81 shRNA (UAS) (100)
GTR15156966 1 Vial

Lentiviral mouse Mus81 shRNA (UAS) - Lentiviral mouse Mus81 shRNA (UAS) (100)

Ask
View Details
Recombinant Staphylococcus epidermidis Probable catabolite control protein A (ccpA)
MBS1292980-01 0.02 mg (E-Coli)

Recombinant Staphylococcus epidermidis Probable catabolite control protein A (ccpA)

Ask
View Details
Recombinant Staphylococcus epidermidis Probable catabolite control protein A (ccpA)
MBS1292980-02 0.02 mg (Yeast)

Recombinant Staphylococcus epidermidis Probable catabolite control protein A (ccpA)

Ask
View Details
Recombinant Staphylococcus epidermidis Probable catabolite control protein A (ccpA)
MBS1292980-03 0.1 mg (E-Coli)

Recombinant Staphylococcus epidermidis Probable catabolite control protein A (ccpA)

Ask
View Details